Why Exosomes & Stem Cells Outperform PRP
Stem Nova’s UCT-MSCs and exosomes are redefining regenerative care — offering consistent, science-backed results far beyond the limitations of PRP.
CATEGORY | PRP | Stem Nova Exosomes + UCT-MSCs |
---|---|---|
Source | Patient’s blood | First-pregnancy umbilical cord tissue |
Consistency | Variable | Standardized 95–97% viability |
Active Ingredients | Platelets, growth factors | Exosomes, cytokines, peptides |
Post-Procedure | Inflammation or bruising | Anti-inflammatory, immune-privileged |
Aesthetic Suitability | Basic facials | Microneedling, RF, lasers |
Session Value | $200–$500 | $1,000–$3,000+ |
Science Level | First-gen | Next-gen, 3D-cultured biologics |
Why Exosomes & UCT-MSCs Are Replacing PRP
- PRP depends on variable patient biology
- 60B+ exosomes & 25M MSCs per Stem Nova vial
- Perfect for topical, RF, and laser recovery
- Better satisfaction & shorter healing time
- Premium value add-on for clinics
“You can’t control what’s in your patient’s blood. But you can control the potency of a vial.”
Advanced Technology = Superior Results
- MicroRNA
- Cytokines
- Signalers & peptides
- 3D-cultured for 20x regenerative yield
“PRP is first-gen regenerative medicine. Exosomes and MSCs are next-gen biologics.”
Higher-Ticket Upsell, Better Patient Experience
- Command $1,000+ per session
- Offer consistent, high-value results
- Become competitive in biohacking & longevity
Perception = Innovation
- Used by elite athletes & influencers
- Trusted in aesthetic medicine & regenerative protocols
PRP has been the go-to for years, but it relies on what the patient can give you. What if you could offer a solution that’s 10x more consistent, more regenerative, and backed by science — with zero blood draw?